{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T02:38:23Z","timestamp":1792636703005,"version":"4.5.0"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T00:00:00Z","timestamp":1785110400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T00:00:00Z","timestamp":1792627200000},"content-version":"vor","delay-in-days":87,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Global Health EDCTP3","award":["101103171"],"award-info":[{"award-number":["101103171"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Health Serv Res"],"DOI":"10.1186\/s12913-026-15140-7","type":"journal-article","created":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T02:46:24Z","timestamp":1785120384000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Healthcare workers\u2019 perceptions of the potential value of whole-genome sequencing for post-exposure management of rifampicin-resistant tuberculosis: a qualitative study"],"prefix":"10.1186","volume":"26","author":[{"given":"Caitlin D.","family":"October","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Busisiwe","family":"Beko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anja","family":"Reuter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent","family":"Rennie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nabila","family":"Ismail","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emilyn","family":"Costa Concei\u00e7\u00e3o","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susanne","family":"Tonsing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rob","family":"Warren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanus","family":"Malherbe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annelies Van","family":"Rie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lario","family":"Viljoen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,27]]},"reference":[{"issue":"9","key":"15140_CR1","doi-asserted-by":"publisher","first-page":"e559","DOI":"10.1016\/S1473-3099(24)00144-0","volume":"24","author":"K Naidoo","year":"2024","unstructured":"Naidoo K, Perumal R, Cox H, Mathema B, Loveday M, Ismail N, et al. The epidemiology, transmission, diagnosis, and management of drug-resistant tuberculosis\u2014lessons from the South African experience. Lancet Infect Dis. 2024;24(9):e559\u201375. https:\/\/doi.org\/10.1016\/S1473-3099(24)00144-0.","journal-title":"Lancet Infect Dis"},{"key":"15140_CR2","volume-title":"Global Tuberculosis Report 2025","author":"World Health Organization","year":"2025","unstructured":"World Health Organization. Global Tuberculosis Report 2025. 1st ed. Geneva: World Health Organization; 2025.","edition":"1"},{"issue":"1","key":"15140_CR3","doi-asserted-by":"publisher","first-page":"2234450","DOI":"10.1080\/17441692.2023.2234450","volume":"18","author":"A South","year":"2023","unstructured":"South A, Dhesi P, Tweed CD, Tsogt B, Staples S, Tukvadze N, et al. Patients\u2019 priorities around drug-resistant tuberculosis treatment: A multi-national qualitative study from Mongolia, South Africa and Georgia. Glob Public Health. 2023;18(1):2234450. https:\/\/doi.org\/10.1080\/17441692.2023.2234450.","journal-title":"Glob Public Health"},{"issue":"10","key":"15140_CR4","doi-asserted-by":"publisher","first-page":"e0309034","DOI":"10.1371\/journal.pone.0309034","volume":"19","author":"D Evans","year":"2024","unstructured":"Evans D, Hirasen K, Ramushu C, Long L, Sinanovic E, Conradie F et al. D <>Gotham editor 2024 Patient and provider costs of the new BPaL regimen for drug-resistant tuberculosis treatment in South Africa: A cost-effectiveness analysis. PLoS ONE 19 10 e0309034 https:\/\/doi.org\/10.1371\/journal.pone.0309034.","journal-title":"PLoS ONE"},{"key":"15140_CR5","doi-asserted-by":"crossref","unstructured":"Wang Z, Willem L, Ndebele F, Concei\u00e7\u00e3o EC, Churchyard G, Callens S. Economic evaluation of whole genome sequencing guided treatment for rifampicin-resistant tuberculosis: a within-trial analysis of the smartt trial. 2026.","DOI":"10.2139\/ssrn.6567738"},{"issue":"1","key":"15140_CR6","doi-asserted-by":"publisher","first-page":"65","DOI":"10.3949\/ccjm.84a.15049","volume":"84","author":"MS Bader","year":"2017","unstructured":"Bader MS, Brooks A, Kelly DV, Srigley JA. Postexposure management of infectious diseases. CCJM. 2017;84(1):65\u201380. https:\/\/doi.org\/10.3949\/ccjm.84a.15049.","journal-title":"CCJM"},{"issue":"2","key":"15140_CR7","doi-asserted-by":"publisher","first-page":"131","DOI":"10.2989\/16085906.2023.2213213","volume":"22","author":"S Norton","year":"2023","unstructured":"Norton S, Moll AP, Madi J, Nkomo N, Brooks RP, Andrews L, et al. Community health workers can be trained to identify patients eligible for tuberculosis preventive therapy, but encounter barriers to programme implementation in KwaZulu-Natal, South Africa. Afr J AIDS Res. 2023;22(2):131\u20135. https:\/\/doi.org\/10.2989\/16085906.2023.2213213.","journal-title":"Afr J AIDS Res"},{"issue":"4","key":"15140_CR8","doi-asserted-by":"publisher","first-page":"159","DOI":"10.5588\/pha.22.0030","volume":"12","author":"DP Baloyi","year":"2022","unstructured":"Baloyi DP, Anthony MG, Meyerson KA, Mazibuko S, Wademan D, Viljoen L, et al. Reasons for poor uptake of TB preventive therapy in South Africa. public health action. 2022;12(4):159\u201364. https:\/\/doi.org\/10.5588\/pha.22.0030.","journal-title":"public health action"},{"key":"15140_CR9","unstructured":"Hoddinott G, Du Preez K, Osman M, Hirsch-Moverman Y, Viljoen L, Myburgh H, Hesseling A. A review of key stakeholders\u2019 perceptions of the impediments and facilitators of the implementation of tuberculosis preventive Therapy (TPT) in South Africa (Policy Brief). South African TB Think Tank; 2020. https:\/\/tbthinktank.org\/wp-content\/uploads\/2022\/08\/2020-Policy-Brief-IMPEDIMENTS-AND-FACILITATORS-of-TB.pdf"},{"issue":"4","key":"15140_CR10","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1080\/17441692.2021.1892793","volume":"17","author":"DK Chandra","year":"2022","unstructured":"Chandra DK, Moll AP, Altice FL, Didomizio E, Andrews L, Shenoi SV. Structural barriers to implementing recommended tuberculosis preventive treatment in primary care clinics in rural South Africa. Glob Public Health. 2022;17(4):555\u201368. https:\/\/doi.org\/10.1080\/17441692.2021.1892793.","journal-title":"Glob Public Health"},{"key":"15140_CR11","doi-asserted-by":"publisher","unstructured":"Purchase SE, Wademan DT, Tshetu NL, Rafique M, Rafique M, Hoddinott G, Seddon JA, et al. Holistic acceptability of an adult levofloxacin formulation in children and adolescents on a tuberculosis preventive treatment trial. PLOS Glob Public Health. 2024;4(7):e0003381. https:\/\/doi.org\/10.1371\/journal.pgph.0003381.","DOI":"10.1371\/journal.pgph.0003381"},{"issue":"1","key":"15140_CR12","doi-asserted-by":"publisher","first-page":"1979281","DOI":"10.1080\/16549716.2021.1979281","volume":"14","author":"AA Ahmed","year":"2021","unstructured":"Ahmed AA, Grammatico M, Moll AP, Malinga S, Makhunga P, Charalambous S, et al. Factors associated with low tuberculosis preventive therapy prescription rates among health care workers in rural South Africa. Global Health Action. 2021;14(1):1979281. https:\/\/doi.org\/10.1080\/16549716.2021.1979281.","journal-title":"Global Health Action"},{"issue":"1","key":"15140_CR13","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1186\/s43058-023-00490-8","volume":"4","author":"BJ Van De Water","year":"2023","unstructured":"Van De Water BJ, Wilson M, Le Roux K, Gaunt B, Gimbel S, Ware NC. Healthcare worker perceived barriers and facilitators to implementing a tuberculosis preventive therapy program in rural South Africa: a content analysis using the consolidated framework for implementation research. Implement Sci Commun. 2023;4(1):107. https:\/\/doi.org\/10.1186\/s43058-023-00490-8.","journal-title":"Implement Sci Commun"},{"issue":"1","key":"15140_CR14","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1186\/s13063-018-3070-0","volume":"19","author":"JA Seddon","year":"2018","unstructured":"Seddon JA, Garcia-Prats AJ, Purchase SE, Osman M, Demers AM, Hoddinott G, et al. Levofloxacin versus placebo for the prevention of tuberculosis disease in child contacts of multidrug-resistant tuberculosis: study protocol for a phase III cluster randomised controlled trial (TB-CHAMP). Trials. 2018;19(1):693. https:\/\/doi.org\/10.1186\/s13063-018-3070-0.","journal-title":"Trials"},{"issue":"1","key":"15140_CR15","doi-asserted-by":"publisher","first-page":"e033945","DOI":"10.1136\/bmjopen-2019-033945","volume":"10","author":"GJ Fox","year":"2020","unstructured":"Fox GJ, Nguyen CB, Nguyen TA, Tran PT, Marais BJ, Graham SM, et al. Levofloxacin versus placebo for the treatment of latent tuberculosis among contacts of patients with multidrug-resistant tuberculosis (the VQUIN MDR trial): a protocol for a randomised controlled trial. BMJ Open. 2020;10(1):e033945. https:\/\/doi.org\/10.1136\/bmjopen-2019-033945.","journal-title":"BMJ Open"},{"issue":"3","key":"15140_CR16","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/S1473-3099(24)00586-3","volume":"25","author":"RE Colman","year":"2025","unstructured":"Colman RE, Seifert M, De La Rossa A, Georghiou SB, Hoogland C, Uplekar S, et al. Evaluating culture-free targeted next-generation sequencing for diagnosing drug-resistant tuberculosis: a multicentre clinical study of two end-to-end commercial workflows. Lancet Infect Dis. 2025;25(3):325\u201334. https:\/\/doi.org\/10.1016\/S1473-3099(24)00586-3.","journal-title":"Lancet Infect Dis"},{"issue":"1","key":"15140_CR17","doi-asserted-by":"publisher","first-page":"00630","DOI":"10.1183\/23120541.00630-2025","volume":"12","author":"M De Diego Fuertes","year":"2026","unstructured":"De Diego Fuertes M, Costa Concei\u00e7\u00e3o E, Wells F, Rennie V, Heupink T, Churchyard G, et al. Targeted and whole-genome sequencing for drug resistance and genetic relatedness inference of rifampicin-resistant Mycobacterium tuberculosis: an in-depth comparison. ERJ Open Res. 2026;12(1):00630\u20132025. https:\/\/doi.org\/10.1183\/23120541.00630-2025.","journal-title":"ERJ Open Res"},{"key":"15140_CR18","volume-title":"WHO consolidated guidelines on tuberculosis: rapid diagnostics for tuberculosis detection; Module 3: Diagnosis. Third edition","author":"World Health Organization","year":"2024","unstructured":"World Health Organization. WHO consolidated guidelines on tuberculosis: rapid diagnostics for tuberculosis detection; Module 3: Diagnosis. Third edition. Geneva: World Health Organization; 2024."},{"key":"15140_CR19","volume-title":"MDR\/RR-TB), 2021\u20132025: Background Document","author":"World Health Organization","year":"2021","unstructured":"World Health Organization. WHO Global Lists of High Burden Countries for Tuberculosis (TB), TB\/HIV and Multidrug. In: rifampicin-Resistant TB, editor. MDR\/RR-TB), 2021\u20132025: Background Document. 1st ed. Geneva: World Health Organization; 2021.","edition":"1"},{"key":"15140_CR20","unstructured":"National Department of Health. Updated RR-TB Clinical Guidelines. South Africa: National Department of Health; 2023."},{"issue":"4","key":"15140_CR21","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1111\/bjhp.12677","volume":"28","author":"C Paynter","year":"2023","unstructured":"Paynter C, McDonald C, Story D, Francis JJ. Application of the theoretical framework of acceptability in a surgical setting: Theoretical and methodological insights. Br J Health Psychol. 2023;28(4):1153\u201368. https:\/\/doi.org\/10.1111\/bjhp.12677.","journal-title":"Br J Health Psychol"},{"key":"15140_CR22","doi-asserted-by":"publisher","unstructured":"Hunter B, Hocking JS, Manski-Nankervis JA, Jung J, Wigan R, Chen MY, et al. Development and acceptability of a digital tool for promoting syphilis testing in Australian general practice: qualitative study using the Theoretical Framework of Acceptability. Sex Health. 2024;21(5). https:\/\/doi.org\/10.1071\/SH24097.","DOI":"10.1071\/SH24097"},{"key":"15140_CR23","doi-asserted-by":"publisher","unstructured":"Laing L, Salema N, Eshimuni, Jeffries M, Shamsuddin A, Sheikh A, Chuter A, et al. Understanding factors that could influence patient acceptability of the use of the PINCER intervention in primary care: a qualitative exploration using the Theoretical Framework of Acceptability. PLoS One. 2022;17(10):e0275633. https:\/\/doi.org\/10.1371\/journal.pone.0275633.","DOI":"10.1371\/journal.pone.0275633"},{"key":"15140_CR24","doi-asserted-by":"publisher","unstructured":"Timm L, Annerstedt KS, Ahlgren J\u00c1, Absetz P, Alvesson HM, Forsberg BC, et al. Application of the Theoretical Framework of Acceptability to assess a telephone-facilitated health coaching intervention for the prevention and management of type 2 diabetes. PLoS One. 2022;17(10):e0275576. https:\/\/doi.org\/10.1371\/journal.pone.0275576.","DOI":"10.1371\/journal.pone.0275576"},{"issue":"1","key":"15140_CR25","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1186\/s12913-017-2031-8","volume":"17","author":"M Sekhon","year":"2017","unstructured":"Sekhon M, Cartwright M, Francis JJ. Acceptability of healthcare interventions: an overview of reviews and development of a theoretical framework. BMC Health Serv Res. 2017;17(1):88. https:\/\/doi.org\/10.1186\/s12913-017-2031-8.","journal-title":"BMC Health Serv Res"},{"issue":"1","key":"15140_CR26","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1186\/s12879-020-4828-z","volume":"20","author":"R Tadokera","year":"2020","unstructured":"Tadokera R, Bekker LG, Kreiswirth BN, Mathema B, Middelkoop K. TB transmission is associated with prolonged stay in a low socio-economic, high burdened TB and HIV community in Cape Town, South Africa. BMC Infect Dis. 2020;20(1):120. https:\/\/doi.org\/10.1186\/s12879-020-4828-z.","journal-title":"BMC Infect Dis"},{"key":"15140_CR27","unstructured":"Provincial TB Dashboard | Western Cape Government [Internet]. [cited 2026 Apr 23]. Available from: https:\/\/www.westerncape.gov.za\/health-wellness\/provincial-tb-dashboard."},{"key":"15140_CR28","unstructured":"National Department of Health, South Africa. Multi-Drug Resistant Tuberculosis: A Policy Framework on Decentralised and Deinstitutionalised Management for South Africa. South Africa: National Department of Health; 2019."},{"key":"15140_CR29","unstructured":"Trint Ltd. Trint [Internet]. 2026 [cited 2026 May 18]. Available from: https:\/\/trint.com\/."},{"key":"15140_CR30","doi-asserted-by":"publisher","unstructured":"Guest G, Namey E, Chen M. A simple method to assess and report thematic saturation in qualitative research. PLoS One. 2020;15(5):e0232076. https:\/\/doi.org\/10.1371\/journal.pone.0232076.","DOI":"10.1371\/journal.pone.0232076"},{"issue":"2","key":"15140_CR31","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1191\/1478088706qp063oa","volume":"3","author":"V Braun","year":"2006","unstructured":"Braun V, Clarke V. Using thematic analysis in psychology. Qualitative Res Psychol. 2006;3(2):77\u2013101. https:\/\/doi.org\/10.1191\/1478088706qp063oa.","journal-title":"Qualitative Res Psychol"},{"issue":"3","key":"15140_CR32","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1080\/14780887.2020.1769238","volume":"18","author":"V Braun","year":"2021","unstructured":"Braun V, Clarke V. One size fits all? What counts as quality practice in (reflexive) thematic analysis? Qualitative Res Psychol. 2021;18(3):328\u201352. https:\/\/doi.org\/10.1080\/14780887.2020.1769238.","journal-title":"Qualitative Res Psychol"},{"issue":"4","key":"15140_CR33","doi-asserted-by":"publisher","first-page":"e066651","DOI":"10.1136\/bmjopen-2022-066651","volume":"13","author":"SG Lapierre","year":"2023","unstructured":"Lapierre SG, Nouvet E, Boutin CA, Rabodoarivelo MS, Mahboob O, Smith MJ, et al. Complexities and benefits of adopting next-generation sequencing-based tuberculosis diagnostics: a qualitative study among stakeholders in low and high-income countries. BMJ Open. 2023;13(4):e066651. https:\/\/doi.org\/10.1136\/bmjopen-2022-066651.","journal-title":"BMJ Open"},{"issue":"12","key":"15140_CR34","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.5588\/ijtld.22.0335","volume":"26","author":"B Memani","year":"2022","unstructured":"Memani B, Furin J, Cox H, Reuter A. A very sneaky bug: perspectives of front-line clinicians on whole-genome sequencing for drug-resistant TB. int j tuberc lung dis. 2022;26(12):1180\u20132. https:\/\/doi.org\/10.5588\/ijtld.22.0335.","journal-title":"int j tuberc lung dis"},{"key":"15140_CR35","doi-asserted-by":"crossref","unstructured":"Trang TPH, Barrenechea-Pulache A, De Wet K, Fanampe B, Charalambous S, Van Rie A. Potentials and challenges of next generation sequencing-guided individualized treatment for management of rifampicin-resistant tuberculosis \u2013 a qualitative study. PLoS One. 2026.","DOI":"10.1371\/journal.pone.0350514"},{"key":"15140_CR36","doi-asserted-by":"publisher","first-page":"161","DOI":"10.3389\/fmed.2020.00161","volume":"7","author":"P Asare","year":"2020","unstructured":"Asare P, Otchere ID, Bedeley E, Brites D, Loiseau C, Baddoo NA, et al. Whole Genome Sequencing and Spatial Analysis Identifies Recent Tuberculosis Transmission Hotspots in Ghana. Front Med. 2020;7:161. https:\/\/doi.org\/10.3389\/fmed.2020.00161.","journal-title":"Front Med"},{"issue":"11","key":"15140_CR37","doi-asserted-by":"publisher","first-page":"e0002479","DOI":"10.1371\/journal.pgph.0002479","volume":"3","author":"S Molldrem","year":"2023","unstructured":"Molldrem S, Bagani S, Subrahmanyam V, Permar R, Matsiri O, Caiphus C, et al. Botswana tuberculosis (TB) stakeholders broadly support scaling up next-generation whole genome sequencing: Ethical and practical considerations for Botswana and global health. Silva DS. editor PLOS Glob Public Health. 2023;3(11):e0002479. https:\/\/doi.org\/10.1371\/journal.pgph.0002479.","journal-title":"editor PLOS Glob Public Health"},{"issue":"3","key":"15140_CR38","doi-asserted-by":"publisher","first-page":"222","DOI":"10.5588\/ijtld.20.0886","volume":"25","author":"A Van Rie","year":"2021","unstructured":"Van Rie A, de Viedma DG, Meehan CJ, Comas I, Heupink TH, De Vos E, et al. Whole-genome sequencing for TB source investigations: principles of ethical precision public health. 25. 2021;25(3):222\u20137. https:\/\/doi.org\/10.5588\/ijtld.20.0886. PubMed PMID: 33688811.","journal-title":"25"}],"container-title":["BMC Health Services Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12913-026-15140-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12913-026-15140-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12913-026-15140-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T01:47:10Z","timestamp":1792633630000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12913-026-15140-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,27]]},"references-count":38,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["15140"],"URL":"https:\/\/doi.org\/10.1186\/s12913-026-15140-7","relation":{},"ISSN":["1472-6963"],"issn-type":[{"value":"1472-6963","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,27]]},"assertion":[{"value":"23 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was reviewed in accordance with the Declaration of Helsinki and approved by the Human Research Ethics Committee (HREC) of the University of Stellenbosch (reference number: N24\/01\/002), City of Cape Town (project ID number: 12071) and the Western Cape Government Department of Health (WC_202407_003). All participants provided written informed consent.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"1457"}}